Literature DB >> 6383055

Argon laser photocoagulation for macular edema in branch vein occlusion. The Branch Vein Occlusion Study Group.

.   

Abstract

The Branch Vein Occlusion Study is a multi-center, randomized, controlled clinical trial designed to answer several questions regarding the management of complications of branch vein occlusion. This report discusses the question, "Is argon laser photocoagulation useful in improving visual acuity in eyes with branch vein occlusion and macular edema reducing vision to 20/40 or worse?" One hundred thirty-nine eligible eyes were assigned randomly to either a treated or an untreated control group. Comparing treated patients to control patients (mean follow-up 3.1 years for all study eyes), the gain of at least two lines of visual acuity from baseline maintained for two consecutive visits was significantly greater in treated eyes (P = .00049, logrank test). Because of this improvement in visual acuity with argon laser photocoagulation of macular edema from branch vein occlusion, we recommend laser photocoagulation for patients with macular edema associated with branch vein occlusion who meet the eligibility criteria of this study.

Entities:  

Mesh:

Year:  1984        PMID: 6383055     DOI: 10.1016/0002-9394(84)90316-7

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  229 in total

1.  Baseline predictors of visual acuity and retinal thickness outcomes in patients with retinal vein occlusion: Standard Care Versus COrticosteroid for REtinal Vein Occlusion Study report 10.

Authors:  Ingrid U Scott; Paul C VanVeldhuisen; Neal L Oden; Michael S Ip; Barbara A Blodi; Mary Elizabeth Hartnett; Geoff Cohen
Journal:  Ophthalmology       Date:  2011-02       Impact factor: 12.079

Review 2.  The management of retinal vein occlusion: is interventional ophthalmology the way forward?

Authors:  H Shahid; P Hossain; W M Amoaku
Journal:  Br J Ophthalmol       Date:  2006-05       Impact factor: 4.638

3.  The effect of arteriovenous sheathotomy on cystoid macular oedema secondary to branch retinal vein occlusion.

Authors:  M T Cahill; P K Kaiser; J E Sears; S Fekrat
Journal:  Br J Ophthalmol       Date:  2003-11       Impact factor: 4.638

4.  Intravitreal triamcinolone acetonide for ischaemic macular oedema caused by branch retinal vein occlusion.

Authors:  S D M Chen; J Lochhead; C K Patel; P Frith
Journal:  Br J Ophthalmol       Date:  2004-01       Impact factor: 4.638

5.  Recurrence of macular edema associated with branch retinal vein occlusion after intravitreal bevacizumab.

Authors:  Narihisa Hanada; Hiroyuki Iijima; Yoichi Sakurada; Mitsuhiro Imasawa
Journal:  Jpn J Ophthalmol       Date:  2011-12-20       Impact factor: 2.447

Review 6.  Use of bevacizumab for macular edema secondary to branch retinal vein occlusion: a systematic review.

Authors:  Taygan Yilmaz; Miguel Cordero-Coma
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-04-27       Impact factor: 3.117

7.  Foveal sensitivity and visual acuity in macular thickening disorders.

Authors:  Nami Chiba; Mitsuhiro Imasawa; Teruhiko Goto; Masahito Imai; Hiroyuki Iijima
Journal:  Jpn J Ophthalmol       Date:  2012-04-11       Impact factor: 2.447

8.  Prospective multicenter study of visual outcomes following three different treatments for macular edema associated with branch retinal vein occlusion: a study by the Japanese BRVO study group.

Authors:  Seiyo Harino; Kenichiro Bessho; Teruyo Kida
Journal:  Jpn J Ophthalmol       Date:  2012-02-23       Impact factor: 2.447

9.  Relationship between perifoveal capillaries and pathomorphology in macular oedema associated with branch retinal vein occlusion.

Authors:  T Murakami; A Tsujikawa; K Miyamoto; A Sakamoto; M Ota; K Ogino; N Yoshimura
Journal:  Eye (Lond)       Date:  2012-06-01       Impact factor: 3.775

10.  Management of branch retinal vein occlusion with vitrectomy and arteriovenous adventitial sheathotomy, the possible role of surgical posterior vitreous detachment.

Authors:  Jérôme Charbonnel; Agnès Glacet-Bernard; Jean-François Korobelnik; Emilienne Nyouma-Moune; Constantin J Pournaras; Joseph Colin; Gabriel Coscas; Gisèle Soubrane
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2003-12-18       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.